IRIS
LAPADULA, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.292
AS - Asia 4.549
EU - Europa 3.402
SA - Sud America 1.290
AF - Africa 130
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 9
Totale 23.682
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.160
SG - Singapore 2.071
CN - Cina 1.143
BR - Brasile 1.100
SE - Svezia 714
HK - Hong Kong 646
RU - Federazione Russa 512
DE - Germania 446
FR - Francia 428
IT - Italia 333
VN - Vietnam 300
FI - Finlandia 266
GB - Regno Unito 241
UA - Ucraina 189
AR - Argentina 79
IN - India 77
CA - Canada 65
BE - Belgio 62
BD - Bangladesh 58
IE - Irlanda 48
IQ - Iraq 43
MX - Messico 41
ID - Indonesia 37
ZA - Sudafrica 37
EC - Ecuador 28
CI - Costa d'Avorio 27
JP - Giappone 26
ES - Italia 25
PL - Polonia 23
TR - Turchia 22
AT - Austria 20
MA - Marocco 19
NL - Olanda 19
PK - Pakistan 19
PY - Paraguay 19
IR - Iran 18
CZ - Repubblica Ceca 16
EG - Egitto 16
LT - Lituania 16
VE - Venezuela 16
SA - Arabia Saudita 14
CL - Cile 12
CO - Colombia 12
UZ - Uzbekistan 12
AZ - Azerbaigian 9
JM - Giamaica 9
PE - Perù 9
EU - Europa 8
DZ - Algeria 7
KE - Kenya 7
UY - Uruguay 7
AU - Australia 6
DK - Danimarca 6
BO - Bolivia 5
HR - Croazia 5
RO - Romania 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
BY - Bielorussia 4
CH - Svizzera 4
IL - Israele 4
NP - Nepal 4
AL - Albania 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
KR - Corea 3
KZ - Kazakistan 3
LB - Libano 3
MN - Mongolia 3
PH - Filippine 3
PS - Palestinian Territory 3
QA - Qatar 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
BG - Bulgaria 2
CR - Costa Rica 2
DM - Dominica 2
EE - Estonia 2
GE - Georgia 2
GF - Guiana Francese 2
HN - Honduras 2
JO - Giordania 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
SN - Senegal 2
TH - Thailandia 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
GA - Gabon 1
Totale 23.664
Salva come PNG Salva come JPEG
Città #
Fairfield 1.879
Woodbridge 1.473
Ashburn 1.241
Houston 1.191
Chandler 1.067
Singapore 1.053
Seattle 798
Ann Arbor 748
Cambridge 683
Hong Kong 642
Wilmington 607
Nyköping 550
Jacksonville 538
Beijing 335
Lawrence 245
Roxbury 245
Nanjing 224
Dallas 216
New York 186
Des Moines 148
Inglewood 145
Princeton 136
Los Angeles 131
Munich 108
São Paulo 99
Boardman 96
Bari 94
Ho Chi Minh City 91
San Diego 85
Santa Clara 82
Dearborn 81
London 66
Shenyang 65
Brussels 62
Moscow 62
Hanoi 60
Brooklyn 58
Paris 52
Buffalo 50
Hebei 50
Dublin 48
Nanchang 44
Turku 42
Jiaxing 39
Helsinki 38
Rio de Janeiro 38
Redwood City 35
Chicago 34
Changsha 32
The Dalles 31
Tianjin 31
Belo Horizonte 29
Boston 27
Columbus 27
Abidjan 26
San Francisco 26
Tokyo 24
Dong Ket 23
Toronto 23
Brasília 22
Guangzhou 22
Jakarta 22
Warsaw 22
Council Bluffs 21
San Jose 21
Nuremberg 20
Hefei 18
Montreal 18
Baghdad 17
Denver 17
Falkenstein 17
Johannesburg 17
Augusta 16
Campinas 16
Frankfurt am Main 16
Jinan 16
Poplar 16
Chennai 15
Dhaka 15
Stockholm 15
Atlanta 14
Da Nang 14
Orem 14
Shanghai 14
Kunming 13
San Mateo 13
Vienna 13
Haiphong 12
Pune 12
Biên Hòa 11
Curitiba 11
Detroit 11
Mexico City 11
Phoenix 11
Porto Alegre 11
Quito 11
Tashkent 11
Washington 11
Ardabil 10
Asunción 10
Totale 16.976
Salva come PNG Salva come JPEG
Nome #
Safety of Long-Term Biologic Therapy in Rheumatologic Patients With a Previously Resolved Hepatitis B Viral Infection 184
No changes in N-terminal pro-brain natriuretic peptide in a longitudinal cohort of patients with systemic sclerosis-associated pulmonary arterial hypertension on therapy with bosentan 177
Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors 175
Correlation between serum amyloid-A and serum levels of proinflammatory cytokines in patients with Behçet's disease 167
AB0836 Drug retention rate of the first tnf inhibitor in radiographic and non radiographic axial spondyloarthritis: data from a multicenter study 167
AB0065 Possible Interplay Between Serum Amyloid-A and Pro-Inflammatory Cytokines Into the Pathogenesis of Behçet's Disease 167
AB0618 A unique ultrasound pattern of adipose tissue in systemic sclerosis patients: a comparison with rheumatoid arthritis patients and healthy controls. two sides of adipose tissue involvement in systemic chronic inflammatory diseases 164
Adalimumab in the treatment of immune-mediated diseases 163
A Case of Osteonecrosis of the Jaw in a Patient with Crohn's Disease Treated with Infliximab 157
Efficacy and safety profile of anti-interleukin-1 treatment in Behçet’s disease: a multicenter retrospective study 156
AB0452 Changes in Lipoproteins Associated with Tocilizumab Treatment Do not Influence the Atherogenic Index of Plasma of Rheumatoid Arthritis Patients: Table 1 156
Early changes of articular cartilage, synovial membrane and subchondral bone in an experimental model of goat osteoarthrtitis 155
Retinal vessels thrombosis as onset manifestation of systemic sclerosis: 3 clinical cases 155
A false occult hepatitis B virus infection developed in a patient with psoriatic arthritis under infliximab and methotrexate therapy 155
Obesity reduces the drug survival of second line biological drugs following a first TNF-α inhibitor in rheumatoid arthritis patients 152
Possible interplay between interleukin-15 and interleukin-17 into the pathogenesis of idiopathic inflammatory myopathies 150
Two-year survival rates of anti-TNF-α therapy in psoriatic arthritis (PsA) patients with either polyarticular or oligoarticular PsA 147
Papular-purpuric gloves and socks syndrome due to parvovirus B19: a report of two simultaneous cases in cohabitant families 147
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: Results from the GISEA register 146
AB0041 Serum Amyloid A Stimulates The Induction of Inflammatory Mediators in Monocytes from Behçet's Disease Patients: A Proof of Concept Study 146
Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives 145
Refractory knee giant cell tumor of the synovial membrane treated with intra-articular injection of Infliximab: A case series and review of the literature 141
Body mass does not affect the remission of psoriatic arthritis patients on anti-TNF-α therapy 141
SAT0216 Chest Ultrasound Signs of Interstitial Lung Disease in Systemic Sclerosis Patients: A Comparison between High Resolution Chest Computed Tomography Findings 141
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: Premises, perils, and perspectives 140
Different switching rate of anti-TNF-α drugs in monotherapy and in combination with methotrexate in a cohort of rheumatoid arthritis patients in the real life 139
Orofacial Manifestations and Temporomandibular Disorders of Systemic Scleroderma: An Observational Study. 138
Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease 137
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis 137
Leucocytoclastic vasculitis as onset symptom of ulcerative colitis 135
Old and new antirheumatic drugs and the risk of hepatotoxicity 134
Update on laser-evoked potential findings in fibromyalgia patients in light of clinical and skin biopsy features 133
Lipid Profile of Rheumatoid Arthritis Patients Treated with Anti-Tumor Necrosis Factor-Alpha Drugs Changes According to Disease Activity and Predicts Clinical Response 132
Golimumab in real-life settings: 2 Years drug survival and predictors of clinical outcomes in rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis 132
Paradoxical mucocutaneous flare in a case of Behçet’s disease treated with tocilizumab 132
Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: An approach to a personalized medicine 132
AN UNWELCOME HOST IN THE PATHOGENESIS OF ARTHRITIDES 131
ANTI-TNFA THERAPY IN PSORIATIC ARTHRITIS: DIFFERENT RATE OF REMISSION IN POLYARTICULAR AND OLIGOARTICULAR SUBSETS 131
Orofacial Manifestations and Temporomandibular Disorders of Sjogren Syndrome: An Observational Study 130
PFAPA syndrome and Behçet’s disease: a comparison of two medical entities based on the clinical interviews performed by three different specialists 129
Serum amyloid-A in Behçet's disease 128
Lipids and atherogenic indices fluctuation in rheumatoid arthritis patients on long-term tocilizumab treatment 127
SAT0212 Pericardial Effusion Related To Systemic Sclerosis: A Possible Contribution of The Serum Levels of Adipokines and Interleukines 126
THU0153 The effect of 5-years b-dmards treatment on different 10-years cardiovascular risk scores applied in rheumatoid arthritispatients 126
Intra-articular therapy with tumor necrosis factor-α antagonists: An update 125
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 125
Management of Small Vessel Vasculitides 124
PRESENT STATUS AND NEW PERSPECTIVES IN NON-STEROIDAL ANTI-INFLAMMATORY DRUGS THERAPY 124
Proinflammatory cytokines and antiskin autoantibodies in patients with inherited epidermolysis bullosa 123
Analysis of subchondral cortical plate and trabecular bone in osteoarthritis experimentally induced in goat tibia. Preliminary results 122
The use of biosimilars in immune-mediated disease: A joint Italian Society of Rheumatology (SIR), Italian Society of Dermatology (SIDeMaST), and Italian Group of Inflammatory Bowel Disease (IG-IBD) position paper 121
Untangling the web of systemic autoinflammatory diseases 121
FRI0110 Methotrexate monotherapy in real life: a drug survival analysis. comparison between very early arthritis and early arthritis cohorts 121
Safety of etanercept and methotrexate in patients with rheumatoid arthritis and hepatitis C virus infection: A multicenter randomized clinical trial 120
The profiling of axial spondyloarthritis patient candidate to a biologic therapy: Consensus from a Delphi-panel of Italian experts 120
LIPID PROFILE OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ANTI-TNF-ALPHA DRUGS CHANGES ACCORDING TO DISEASE ACTIVITY RESPONSE 120
High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy: Data from GISEA, the Italian biologics register 118
Early-onset sarcoidosis caused by a rare CARD15/NOD2 de novo mutation and responsive to infliximab: a case report with long-term follow-up and review of the literature 118
Drug survival on TNF inhibitors: 2003-2004 data from Italian National Register (GISEA Register) 117
Improvement of renal function and disappearance of hepatitis B virus DNA in a patient with rheumatoid arthritis and renal amyloidosis following treatment with infliximab 117
ASSOCIATION OF SYSTEMIC SCLEROSIS AND PSORIATIC ARTHRITIS: A CASE REPORT 116
Longterm clinical outcomes in 420 patients with psoriatic arthritis taking anti-tumor necrosis factor drugs in real-world settings 116
Joint and tendon involvement predict disease progression in systemic sclerosis: A EUSTAR prospective study 115
ISOLATED STERNOCLAVICULAR JOINT ARTHRITIS IN HEROIN ADDICTS AND/OR HIV POSITIVE PATIENTS: THREE CASES 114
Early clinical response predicts low disease activity at one year in rheumatoid arthritis patients on treatment with certolizumab in real-life settings. An appraisal of the Italian registry GISEA 114
Obesity and Inflammation – Targets for OA Therapy 113
Evaluation of Serum Levels of Adipokines and Interleukines in Pericardial Effusion Related to Systemic Sclerosis 113
Digital laser doppler flowmetry may discriminate "limited" from "diffuse" systemic sclerosis 112
Bone and kidney toxicity induced by nucleotide analogues in patients affected by HBV-related chronic hepatitis: a longitudinal study. 112
Diagnosis of latent tuberculosis and prevention of reactivation in rheumatic patients receiving biologic therapy: International recommendations 111
AB0245 PREDICTORS OF BIOLOGIC THERAPY DISCONTINUATION IN RHEUMATOID ARTHRITIS PATIENTS AFTER REMISSION ACHIEVEMENT: A MONOCENTRIC OBSERVATIONAL STUDY FROM BIOLOGIC APULIAN REGISTRY (BIOPURE) 111
Serum cartilage oligomeric matrix protein (COMP) following infliximab treatment in patients with rheumatoid arthritis: Analitical performances and clinical correlations 110
OP0129 Drug survival on anti-tnf-alpha in psoriatic arthritis patients with axial involvement and analysis of predictors 109
Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis 109
Different joint and skin clinical response of patients with psoriatic arthritis treated with infliximab 109
Update on the profile of the EUSTAR cohort: An analysis of the EULAR Scleroderma Trials and Research group database 108
Anti-cyclic citrullinated peptide autoantibodies measured by an automated enzyme immunoassay: analytical performance and clinical correlations 107
). Analysis of subchondral cortical plate and trabecular bone in osteoarthritis experimentally induced in goat tibia. Preliminary results. 106
Sarcoidosis presenting with Raynaud's syndrome: a case report 106
Efficacy and safety of certolizumab pegol in rheumatoid arthritis: Meeting rheumatologists' requirements in routine clinical practice 106
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response 106
PHENOTYPING OF CHONDROCYTES FROM HUMAN OSTEOARTHRITIC CARTILAGE: CHONDROCYTE EXPRESSION OF BETA INTEGRINS AND CORRELATION WITH ANATOMIC INJURY 105
Prevalence of anti-CCP antibodies in systemic sclerosis 105
Improvement of Refractory Dysphagia in Patients with Idiopathic Inflammatory Myopathies Receveing Immunoglobulin Intravenous Therapy 105
Isolated thrombocytopenia associated with low dose methotrexate therapy 104
Intra-articular clodronate for the treatment of knee osteoarthritis: dose ranging study vs hyaluronic acid 103
Laser-evoked potentials habituation in fibromyalgia 102
THU0168 Relationships between body fat composition assessed with bioelectrical impedance analysis, serum adipokines and disease activity in patients with rheumatoid arthritis 102
Distribution of HLA-B27 subtypes in Sardinia and continental Italy and their association with spondylarthropathies 102
A CASE OF SWEET'S SYNDROME WITH RHEUMATIC ONSET 101
The pathophysiology of osteoarthritis 101
null 101
Intentional etanercept use during pregnancy for maintenance of remission in rheumatoid arthritis 101
Response of cartilage oligomeric matrix protein to monoclonal antibody drugs in patients with rheumatoid arthritis 101
EARLY CHANGES OF ARTHICULAR CARTILAGE, SYNOVIAL MEMBRANE AND SUBCHONDRAL BONE IN AN EXPERIMENTAL MODEL OF GOAT OSTEOARTHRITIS 99
MONOCLONAL ANTIBODY INVESTIGATION IN RHEUMATOID ARTHRITIS: PRESENCE OF A T CELL SUBPOPULATION BEARING A DOUBLE MARKER 99
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry 99
Giant Cell Tumor of Synovial Sheath: Of Two Cases Treated with Intra-Articular Infiltration of Infliximab 99
Cutaneous lesions as presenting symptoms of primary biliary cirrhosis: an undifferentiated connective tissue disease-like onset 98
null 97
Totale 12.586
Salva come PNG Salva come JPEG
Categoria #
all - tutte 105.386
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.386
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.373 0 0 0 0 0 140 208 233 194 285 169 144
2021/20221.797 125 209 23 111 87 118 85 102 102 112 293 430
2022/20232.808 435 326 192 265 321 358 58 287 449 19 59 39
2023/2024758 77 174 32 55 49 176 17 43 3 33 12 87
2024/20253.723 63 65 342 103 56 311 275 391 165 216 576 1.160
2025/20264.285 1.138 384 472 969 918 404 0 0 0 0 0 0
Totale 24.341